SMAD2 and prostate cancer: WWP1 negatively regulates this pathway by ubiquitinating and degrading critical components like Smad2 and TβRI, which in prostate cancer (PCa) results in WWP1 overexpression that inhibits TGF-β-induced gene expression and promotes cell proliferation (Chen et al., 2007).